scispace - formally typeset
Open AccessJournal ArticleDOI

Antimicrobial activities of silver dressings: an in vitro comparison.

TLDR
Understanding the characteristics of silver-coated or -impregnated dressings may enable them to be targeted more appropriately according to the specific requirements for use of a particular dressing, as in for prophylaxis in skin grafting or for an infected wound with MRSA.
Abstract
A range of silver-coated or -impregnated dressings are now commercially available for use but comparative data on their antimicrobial efficacies are limited. The antibacterial activities of five commercially available silver-coated/impregnated dressings were compared against nine common burn-wound pathogens, namely methicillin-sensitive and -resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, Proteus vulgaris, Acinetobacter baumannii and a multi-drug-efflux-positive Acinetobacter baumannii (BM4454), using a broth culture method. The rapidity and extent of killing of these pathogens under in vitro conditions were evaluated. All five silver-impregnated dressings investigated exerted bactericidal activity, particularly against Gram-negative bacteria, including Enterobacter species, Proteus species and E. coli. The spectrum and rapidity of action, however, ranged widely for different dressings. Acticoat and Contreet had a broad spectrum of bactericidal activities against both Gram-positive and -negative bacteria. Contreet was characterized by a very rapid bactericidal action and achieved a reduction of > or =10,000 c.f.u. ml(-1) in the first 30 min for Enterobacter cloacae, Proteus vulgaris, Pseudomonas aeruginosa and Acinetobacter baumanii. Other dressings demonstrated a narrower range of bactericidal activities. Understanding the characteristics of these dressings may enable them to be targeted more appropriately according to the specific requirements for use of a particular dressing, as in for prophylaxis in skin grafting or for an infected wound with MRSA.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Silver nanoparticles-modified films versus biomedical device-associated infections

TL;DR: The difficulties in diagnosing and treating biomedical device-associated infections as well as the state of arts in fabricating the Ag NPs-modified films for antibacterial applications are reviewed.
Journal ArticleDOI

Algal production of nano-silver and gold: Their antimicrobial and cytotoxic activities: A review.

TL;DR: The biosynthesized NPs using algae exerted an outstanding antimicrobials and cytotoxic effect and was hailed as one of the most promising and novel therapeutic agents of biological origin.
Journal ArticleDOI

Cytotoxicity and genotoxicity of nano-silver in mammalian cell lines

TL;DR: Nano-silver can cause primary DNA damage and cytotoxicity but not mutagenicity in cultured mammalian cells, and is more cytotoxic in absence of S-9 metabolic activation system and at the BEAS-2B cells.
Journal ArticleDOI

Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Concerns about Potential Application in Dental Practice.

TL;DR: This study highlighted potential usefulness of AgNPs against oral anaerobic Gram-positive and Gram-negative bacterial infections and aerobic Staphylococci strains provided that pharmacological activity and risk assessment are carefully performed.
Journal ArticleDOI

Characterization and evaluation of silver release from four different dressings used in burns care

TL;DR: The morphology of four commercial Ag dressings is characterized by scanning electron microscopy and the mean inhibitory concentrations are exceeded for most common pathogens in serum substitute and sterile water, but the presence of high Cl(-) concentrations tend to inactivate the dressings.
References
More filters
Journal ArticleDOI

Bacterial silver resistance: molecular biology and uses and misuses of silver compounds

TL;DR: Resistance to silver compounds as determined by bacterial plasmids and genes has been defined by molecular genetics and the use of molecular epidemiological tools will establish the range and diversity of such resistance systems in clinical and non-clinical sources.
Journal ArticleDOI

Silver-based crystalline nanoparticles, microbially fabricated

TL;DR: Transmission electron microscopy, quantitative energy-dispersive x-ray analysis, and electron diffraction established that the crystals comprise at least three different types, found both in whole cells and thin sections, in Pseudomonas stutzeri AG259.
Journal ArticleDOI

Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?

TL;DR: A completely new approach using supercritical carbon dioxide to impregnate silicone with nanoparticulate silver metal allows for the first time silver impregnation of medical polymers and promises to lead to an antimicrobial biomaterial whose activity is not restricted by increasing antibiotic resistance.
Journal ArticleDOI

Silver. I: Its antibacterial properties and mechanism of action.

TL;DR: The main mechanism of action of silver products, which are broad-spectrum antibiotics and are not yet associated with drug resistance, is described.
Related Papers (5)